Physician profile
Jeffrey Carroll
NPI 1255360897
$12,811.70
in general payments reported to CMS, 2019-2025
19 companies · $1,368 in 2025
The $1,368 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,524 · 2020: $2,407 · 2021: $2,635 · 2022: $3,992 · 2023: $439 · 2024: $446 · 2025: $1,368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,252.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $6,210.24 | 2020-2024 | |
| Depuy Synthes Sales INC. | $1,707.12 | 2019-2025 | Na, Inhance, Tfn-Advance |
| Smith+Nephew, INC. | $1,481.29 | 2019-2025 | Bone Anchors With Arthroscopic Delivery System, Healicoil, Firstpass |
| Anika Therapeutics, INC. | $832.20 | 2022 | |
| Medical Device Business Services, INC. | $563.76 | 2022-2025 | Velys |
| Lima USA, INC. | $540.68 | 2020 | |
| Arthrex, INC. | $397.68 | 2022 | |
| Stryker Corporation | $277.66 | 2022-2025 | Blueprint Patient Specific Instrumentation, Mako |
| Axogen | $248.50 | 2023 | Avance Nerve Graft |
| Trice Medical, INC. | $200.00 | 2019 | |
| Ermi LLC | $86.13 | 2020-2021 | |
| Si-Bone, INC. | $82.24 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $71.63 | 2021-2024 | Exparel, Iovera |
| Bioventus LLC | $33.55 | 2019-2022 | |
| Pacira Therapeutics, INC. | $20.08 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $17.64 | 2025 | Physio-Stim |
| Wright Medical Technology, INC. | $14.83 | 2019 | |
| Cranial Technologies, INC | $14.09 | 2020 | |
| Dynasplint Systems INC. | $12.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Carroll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.